CTRI/2024/06/069186
Not yet recruiting
未知
Tumour Infiltrating Lymphocytes (TIL) and its correlation with prognostic pathologic parameters in resectable Oral Squamous Cell Carcinoma - NI
Datta Meghe Institute of Higher Education and Research (DMIHER)0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Datta Meghe Institute of Higher Education and Research (DMIHER)
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Cases diagnosed as Oral Squamous Cell Carcinoma of all the three Broder’s grade on biopsy irrespective of gender and age.
- •2\)The patients whose surgical specimen is resected and submitted for histopathological examination, to surgical pathology section of Department of Pathology, JNMC, irrespective of surgery type
Exclusion Criteria
- •1\) The patients with inadequate clinical records.
- •2\) The patients undergoing resection surgery for recurrent tumours of Squamous Cell Carcinoma.
- •3\) Patients who receive pre\-operative chemotherapy or any other monoclonal antibody treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
ovel marker in predicting nodal metastasis in oral squamous cell carcinoma.CTRI/2023/08/055965Kasturba Medical College and Hospital, Manipal.
Recruiting
Early Phase 1
A Clinical Study on TIL for the Treatment of Advanced Solid TumorsAdvanced Solid TumorTumor Infiltrating LymphocytesTreatment Side EffectsEffects of ImmunotherapyNCT05087745Shanghai Juncell Therapeutics50
Completed
Not Applicable
Tumor immune infiltrates as prognostic biomarkers in oral cancerCTRI/2020/07/026335Kinjal Shankar Majumdar111
Terminated
Phase 1
TIL for Patients With Advanced Solid TumorAdvanced Solid TumorNCT06334783Hervor Therapeutics5
Terminated
Not Applicable
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor InfiltrationMelanomaNCT02339987Saint John's Cancer Institute27